Lupus News

More than 50% of adults aged 45 years or older with some form of arthritis are currently going untreated, despite a substantial proportion experiencing severe symptoms and poor physical function, according to data published in the Journal of Clinical Rheumatology.

The use of wearable devices that track movement is effective in significantly increasing the amount of and time spent performing moderate to vigorous physical activity, with high short-term adherence, among patients with rheumatic and musculoskeletal diseases, according to findings published in Arthritis Care & Research.

To increase the speed with which new treatments for childhood-onset systemic lupus erythematosus are studied, researchers should look to specialized networks and trial designs successfully used in other rare diseases, according to a review published in the Annals of the Rheumatic Diseases.

When it comes to biologic therapy options, patients with rheumatoid arthritis are generally open to, and express high satisfaction with, IV treatments, according to findings published in Arthritis Care & Research.

All-cause mortality among white, African-American and Hispanic patients with end-stage renal disease related to lupus nephritis decreased considerably between 1995 and 2014, according to findings published in Arthritis & Rheumatology.

Researchers at Emory University who initiated an intervention including pre- and day-of-visit planning, weekly reviews and monthly feedback increased combination pneumococcal vaccination rates among patients with systemic lupus erythematosus from 10% to 59%, according to findings published in the Journal of Rheumatology.

The Canadian Rheumatology Association has issued strong recommendations in favor of cardiovascular risk evaluations, as well as annual, single-dose inactivated influenza vaccinations, in the management and assessment of patients with systemic lupus erythematosus, according to findings published in the Journal of Rheumatology.

Most adults with childhood-onset systemic lupus erythematosus develop significant damage at a young age and do not achieve drug-free remission, negatively impacting their health-related quality of life, according to findings published in Arthritis & Rheumatology.

Patients with systemic sclerosis that overlaps with systemic lupus erythematous are generally younger at the time of diagnosis, more frequently demonstrate pulmonary arterial hypertension and less often have cutaneous sclerosis symptoms, according to recent findings in the Journal of Rheumatology.

Results from a 20-year cohort study revealed that women with a history of depression had a more than twofold increased risk for systemic lupus erythematosus compared to those without depression.